Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Open-label Study to Assess the Efficacy and Safety of Tocilizumab in Patients With Active Schnitzler's Syndrome

NCT03046381 is registered in ClinicalTrials.gov with Karoline Krause as lead sponsor.

NCT NCT03046381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03046381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Open-label Study to Assess the Efficacy and Safety of Tocilizumab in Patients With Active Schnitzler's Syndrome
Lead sponsor
Karoline Krause
Phase
Phase 2
Overall status
Completed
Start date
July 19, 2017
Completion date
April 10, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schnitzler's syndrome